Abstract
Due to its consistent elevation in PCOS and correlation with polycystic ovarian morphology, AMH has been proposed as a marker of the disease. Prior studies reporting thresholds of AMH for a diagnosis of PCOS have been limited by small sample size, inappropriate control populations, and heterogeneous AMH assays. We sought to evaluate the accuracy of a standardized AMH assay as a predictor of PCOS diagnosis in an age and BMI-stratified analysis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
